(Q45876542)

17 December 2017

title

Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo (English)

1 reference

17 December 2017

1 reference

2

1 reference

17 December 2017

author name string

Frank S

1

1 reference

17 December 2017

Strauss J

3

1 reference

17 December 2017

Hrzenjak A

4

1 reference

17 December 2017

Kostner GM

5

1 reference

17 December 2017

publication date

1 March 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

425-430

1 reference

17 December 2017

The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

RNase III cleaves eukaryotic preribosomal RNA at a U3 snoRNP-dependent site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Purification and characterization of the Pac1 ribonuclease of Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Virus treatment questioned after gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

High-capacity adenoviral vectors for gene transfer and somatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

A new technique for the assay of infectivity of human adenovirus 5 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Structural requirements of apo-a for the lipoprotein-a assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

Lipoprotein Lp(a) and the risk for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Escherichia coli ribonuclease III cleavage sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301434

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301434

1 reference

17 December 2017

Dimensions Publication ID

1024807867

0 references

1 reference

17 December 2017